Supernus Pharmaceuticals Inc (SUPN)
35.81
-0.31
(-0.86%)
USD |
NASDAQ |
Nov 21, 16:00
35.81
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Price: 35.81 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 35.66 | 36.50 | 35.32 | 36.12 | 202895.0 |
| Nov 19, 2024 | 34.88 | 35.64 | 34.88 | 35.53 | 211609.0 |
| Nov 18, 2024 | 35.61 | 36.20 | 34.86 | 35.25 | 223995.0 |
| Nov 15, 2024 | 36.39 | 36.39 | 35.23 | 35.57 | 403290.0 |
| Nov 14, 2024 | 37.78 | 38.32 | 35.87 | 36.18 | 370984.0 |
| Nov 13, 2024 | 37.94 | 38.32 | 37.18 | 37.77 | 403586.0 |
| Nov 12, 2024 | 36.84 | 37.99 | 36.84 | 37.83 | 425682.0 |
| Nov 11, 2024 | 36.93 | 37.26 | 36.02 | 36.61 | 266696.0 |
| Nov 08, 2024 | 36.50 | 36.78 | 35.87 | 36.60 | 578650.0 |
| Nov 07, 2024 | 37.75 | 37.75 | 36.23 | 36.40 | 788447.0 |
| Nov 06, 2024 | 35.88 | 38.21 | 35.33 | 37.75 | 724712.0 |
| Nov 05, 2024 | 39.37 | 39.37 | 33.43 | 34.74 | 945125.0 |
| Nov 04, 2024 | 33.96 | 34.96 | 33.70 | 34.70 | 450627.0 |
| Nov 01, 2024 | 34.22 | 34.55 | 33.80 | 33.97 | 788776.0 |
| Oct 31, 2024 | 34.69 | 35.03 | 34.01 | 34.07 | 377694.0 |
| Oct 30, 2024 | 34.09 | 35.56 | 33.95 | 34.87 | 344750.0 |
| Oct 29, 2024 | 34.00 | 34.38 | 33.73 | 34.38 | 272778.0 |
| Oct 28, 2024 | 34.32 | 34.68 | 34.00 | 34.16 | 260462.0 |
| Oct 25, 2024 | 33.80 | 34.54 | 33.80 | 33.93 | 175860.0 |
| Oct 24, 2024 | 33.88 | 34.30 | 33.70 | 33.80 | 282806.0 |
| Oct 23, 2024 | 33.54 | 33.92 | 33.35 | 33.87 | 225361.0 |
| Oct 22, 2024 | 33.51 | 34.05 | 33.27 | 33.71 | 140764.0 |
| Oct 21, 2024 | 34.53 | 34.53 | 33.64 | 33.67 | 220911.0 |
| Oct 18, 2024 | 34.09 | 34.67 | 33.71 | 34.54 | 248863.0 |
| Oct 17, 2024 | 34.03 | 34.10 | 33.57 | 33.84 | 267919.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.45
Minimum
Mar 18 2020
42.03
Maximum
Feb 02 2023
28.98
Average
29.38
Median
May 11 2021
Price Benchmarks
| Regeneron Pharmaceuticals Inc | 744.42 |
| United Therapeutics Corp | 366.97 |
| Ligand Pharmaceuticals Inc | 116.89 |
| Tonix Pharmaceuticals Holding Corp | 0.2015 |
| Agios Pharmaceuticals Inc | 55.55 |
Price Related Metrics
| PE Ratio | 33.48 |
| PS Ratio | 3.058 |
| PEG Ratio | 0.2081 |
| Price to Book Value | 1.963 |
| Price to Free Cash Flow | 11.59 |
| Earnings Yield | 2.99% |
| Market Cap | 1.977B |
| PEGY Ratio | 0.2081 |
| Operating PE Ratio | 27.39 |
| Normalized PE Ratio | 28.31 |